Novo A/S »

4d Molecular Therapeutics In shares owned by Novo A/S

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Novo A/S

Quarter filed Position value Share count Share price at filing
2023-09-30 $15M 1.2M 12.73
2023-06-30 $18M 1.0M 18.07
2023-03-31 $12M 700k 17.19

More positions owned by Novo A/S

Brookfield Corp Cl A Ltd Vt Sh (BN)
Asml Holding N V N Y Registry Shs (ASML)
salesforce (CRM)
Corcept Therapeutics Incorporated (CORT)
Lanzatech Global (LNZA)
Cable One (CABO)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Disc Medicine (IRON)
Mirum Pharmaceuticals (MIRM)
Alibaba Group Hldg Sponsored Ads (BABA)
Vaxcyte (PCVX)
Arcellx Common Stock (ACLX)
Apple (AAPL)
BioMarin Pharmaceutical (BMRN)
Edgewise Therapeutics (EWTX)

View all positions for Novo A/S

Top funds holding 4d Molecular Therapeutics In

Viking Global Investors
RA Capital Management
BVF
VR Adviser
Henderson Group
Vanguard Group
Arrowpoint Asset Management
Casdin Capital
Goldman Sachs Group
Dimensional Fund Advisors
Deutsche Bank Aktiengesellschaft
Eagle Health Investments
Assenagon Asset Management
Jpmorgan Chase & Co
Point72 Asset Management

View all funds holding 4d Molecular Therapeutics In